# First pathologically confirmed case of concurrent primary renal cell carcinoma and metastatic lung adenocarcinoma in the same kidney

**Authors:** Hua Tang, Shengchun Zhang, Jian Chen, Yongfu Wang, Changping Guo, Ting Yu, Dechuan Ye

PMC · DOI: 10.3389/fonc.2026.1767473 · Frontiers in Oncology · 2026-02-10

## TL;DR

This paper reports the first confirmed case of a kidney containing both a primary kidney cancer and a metastatic lung cancer, highlighting the importance of detailed pathology in diagnosis.

## Contribution

The paper presents the first pathologically confirmed case of concurrent primary kidney cancer and metastatic lung cancer in the same kidney.

## Key findings

- A patient had a primary clear cell renal cell carcinoma and metastatic lung adenocarcinoma in the same kidney.
- Histopathological confirmation was essential to distinguish between the two distinct tumors.
- The patient responded positively to targeted therapy after accurate diagnosis.

## Abstract

The coexistence of a primary tumor and a histologically distinct metastasis within the same organ presents a rare diagnostic dilemma, challenging the classical criteria for multiple primary malignant neoplasms (MPMNs). We report the first pathologically confirmed case of synchronous primary clear cell renal cell carcinoma (RCC) and metastatic lung adenocarcinoma within the same kidney.

A patient with tumors in the left lung, right femur, and left kidney underwent laparoscopic left nephrectomy. Postoperative pathology surprisingly identified two distinct lesions: a primary clear cell RCC and a metastatic adenocarcinoma. Subsequent biopsies confirmed the lung as the primary source of the adenocarcinoma (EGFR L858R mutation). The patient was treated with furmonertinib and radiotherapy.

This case underscores the critical importance of histopathological confirmation in complex presentations. It illustrates that even with imaging suggestive of a single primary carcinoma, meticulous pathological evaluation is essential to uncover synchronous MPMNs, thereby guiding precise therapy. The patient demonstrated a positive response to targeted treatment.

## Linked entities

- **Genes:** EGFR (epidermal growth factor receptor) [NCBI Gene 1956]
- **Chemicals:** furmonertinib (PubChem CID 118861389)
- **Diseases:** renal cell carcinoma (MONDO:0005086), lung adenocarcinoma (MONDO:0005061)

## Full-text entities

- **Genes:** MME (membrane metalloendopeptidase) [NCBI Gene 4311] {aka CALLA, CD10, CMT2T, NEP, SCA43, SFE}, PAX8 (paired box 8) [NCBI Gene 7849] {aka PAX-8}, NAPSA (napsin A aspartic peptidase) [NCBI Gene 9476] {aka KAP, Kdap, NAP1, NAPA, NR1H2-AS1, SNAPA}, EGFR (epidermal growth factor receptor) [NCBI Gene 1956] {aka ERBB, ERBB1, ERRP, HER1, NISBD2, NNCIS}, TTF1 (transcription termination factor 1) [NCBI Gene 7270] {aka TTF-1, TTF-I}, KRT7 (keratin 7) [NCBI Gene 3855] {aka CK7, K2C7, K7, SCL}, mucin [NCBI Gene 100508689]
- **Diseases:** bone metastasis (MESH:D009362), MPMNs (MESH:D009378), hypertension (MESH:D006973), carcinogens (MESH:D011230), primary (MESH:D010538), bone (MESH:D001847), femoral lesion (MESH:D020428), weight loss (MESH:D015431), renal lesions (MESH:D007674), primary renal malignancy (MESH:D001932), femoral tumor (MESH:D005266), Left kidney clear cell carcinoma (MESH:D002292), alcohol abuse (MESH:D000437), hip pain (MESH:D010146), bone tumor (MESH:D001859), diabetes (MESH:D003920), lung lesion (MESH:D008171), Left lower lobe adenocarcinoma (MESH:D000230), carcinoma (MESH:D009369), lung cancer (MESH:D008175), reactive edema (MESH:D004487), metastatic disease (MESH:D000092182), Urinary and Male Genital Tumors (MESH:D005834), hemorrhage (MESH:D006470), lung adenocarcinoma (MESH:D000077192), fever (MESH:D005334), renal tumor (MESH:D007680), renal (MESH:D006030), non-small cell lung cancers (MESH:D002289), renal mass (MESH:C536030)
- **Chemicals:** H&amp;E (MESH:D006371), Hematoxylin (MESH:D006416), asbestos (MESH:D001194), eosin (MESH:D004801), Furmonertinib (MESH:C000705711)
- **Species:** Homo sapiens (human, species) [taxon 9606], Nicotiana tabacum (American tobacco, species) [taxon 4097]
- **Mutations:** L858R

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12929116/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12929116/full.md

## References

14 references — full list in the complete paper: https://tomesphere.com/paper/PMC12929116/full.md

---
Source: https://tomesphere.com/paper/PMC12929116